The Japanese Substance In The “Top Position” As Therapy For Post-Vaccine and Post-COVID Syndromes — Dr. Peter McCullough (VIDEO)

While Fauci was lining the pockets of big pharma by peddling experimental mRNA vaccines, Dr. Peter McCullough was hard at work determining safe, scientific ways to combat spike protein effects.

As a preeminent cardiologist, and one of the most trusted medical voices during the pandemic, Dr. McCullough is dedicated to determining what are – and what are not – effective ways to overcome COVID-19 and COVID-19 vaccine injuries.

Watch him talk about the Japanese substance nattokinase – which Dr. McCullough says “is in the top position as a therapy for these post-vaccine and post-COVID syndromes.”

Watch (transcript of highlights below):

Dr. McCullough: “So we have a situation where the genetic materials is long lasting, spike protein production appears to be underway and lasting for a long period of time — and accumulating every six month shots. And then intervening covid means accumulation of spike protein. Three supportive papers: One, I think high quality preclinical paper by Tanaka and colleagues show that nattokinase — an enzymatic product of the fermentation of soy — does attack proteolytic cleavage joints in the spike protein and effectively dissolves it in cell lici models and other models. It was very convincing. Additionally, there is a Syrian protease that can be harvested from river worms in Japan. That efficiently breaks down spike protein as well that — it looks like it could be available as an intravenous formulation. So we have no human data, but this looks enormously promising.

Nattokinase in particular, since it’s already used as a supplement by the Japanese for a couple decades now as anti-atherosclerotic — it is thrombolytic. So the caveats are bleeding. It’s derived from soy. So soy allergies are a caveat. We’d hope that big pharma would pick this up in development. But, you know, a development time from stage one all the way to large stage three clinical trials with hard outcomes could be 20 years. And many think it’s just too long. They have to take action now. So right now, nattokinase, I think is in the top position as a therapy for these post-vaccine and post-COVID syndromes.”

Nattokinase is one of the key ingredients in The Wellness Company’s Spike Support formula (ordering through this link and the links below benefits Gateway Pundit).

People are saying about The Wellness Company’s Spike Support Formula:

“I saw Dr. McCullough talk about the product and decided to give it a try. A month and a half later, I feel sooo much better. I also have recommended the product to family members to help them detox from the painful side effects of the vaccine.”

“I feel like I have had brain fog for the past 18 months and after taking this supplement noticed the fog lifting finally. I plan to buy more for myself and now a friend suffering from heart issues.”

“I am grateful for the Wellness Company and for you coming out with this spike protein vitamins. I am a big believer in natural healing and not pharmaceutical drugs. Thank you for doing what is right and for speaking truth in a world that is so dark.”

In The Wellness Company’s Spike Support Formula you will find:

– Nattokinase (dissolves spike protein)
– Selenium (aids in helping the body repair itself and recover)
– Dandelion root (acts as a detoxifying agent supporting better liver function)
– Black sativa extract (may facilitate cellular repair)
– Green tea extract (provides added defenses at the cellular level through scavenging for free radicals)
– Irish sea moss (could help rebuild damaged tissue and muscle)

According to The Wellness Company, purchasing all the separate ingredients of the Spike Support Formula would be over $100 – you can save 36% with the unique formulation in The Wellness Company’s Spike Support Formula.

Click here to order the Spike Support Formula today!

The post The Japanese Substance In The “Top Position” As Therapy For Post-Vaccine and Post-COVID Syndromes — Dr. Peter McCullough (VIDEO) appeared first on The Gateway Pundit.